GLP-1 itself is a hormone secreted by the intestines in response to food intake, which interacts with receptors in the brain to signal satiety and reduce appetite
CONCLUSION The potential of these new therapies to effectively treat obesity and T2DM and radically reduce their complications pose a major challenge to the health authorities who will need to decide how these new possibilities should be implemented to the benefit of the people at risk
Since this may be expensive, though, it may create a barrier for companies to explore this option
They promised cheap access to compounded versions of the medications Ozempic (which includes the active ingredient semaglutide) and Mounjaro in the middle of an unprecedented global shortages
Gut Microbes, 11(3), 465-480
For example, in laboratory studies, ovariectomized female rats increase their food intake